Bioxytran, Inc.
BIXT
$0.07
$0.002.21%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -898.59% | 102.62% | -168.78% | -28.34% | 40.69% |
| Total Depreciation and Amortization | 68.00% | 31.58% | -34.48% | 93.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | 2,391.20% | -16.67% |
| Total Other Non-Cash Items | 72.18% | -131.89% | 589.01% | -1,045.00% | -72.93% |
| Change in Net Operating Assets | 111.86% | -58.41% | 282.95% | -66.42% | -44.41% |
| Cash from Operations | 48.57% | 51.76% | -479.37% | 160.00% | -4.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.82% | -- | 100.00% | -12.04% | -1,642.86% |
| Cash from Investing | 88.82% | -- | 100.00% | -12.04% | -1,642.86% |
| Total Debt Issued | -56.45% | -43.18% | 370.73% | -158.29% | 944.55% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.39% | -43.18% | 370.73% | -158.29% | 44.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,050.00% | -50.00% | 97.29% | -239.15% | 505.71% |